Literature DB >> 6341151

Metabolic studies in chlorpropamide-alcohol flush positive and negative Type 2 (non-insulin dependent) diabetic patients with and without retinopathy.

A H Barnett, A J Spiliopoulos, D A Pyke, W A Stubbs, J Burrin, K G Alberti.   

Abstract

Serum insulin and blood metabolite responses to oral glucose with and without intravenous naloxone were measured in 24 chlorpropamide-alcohol flush positive and negative Type 2 (non-insulin dependent) diabetic patients with and without retinopathy. In the chlorpropamide-alcohol flush positive patients with retinopathy, fasting blood glucose was increased greater than 40% and the serum triglycerides were increased over twofold compared with each of the other three groups. Following oral glucose (50 g), the chlorpropamide-alcohol flush positive diabetic patients with complications had a lower serum insulin and higher blood glycerol than the other three groups. Thus, chlorpropamide-alcohol flush positive subjects with retinopathy showed distinct metabolic differences from the other three groups. There was no evidence that opiate-receptors influenced the metabolic response to oral glucose in the Type 2 diabetic patients since the infusion of intravenous naloxone produced no effect on the serum insulin or blood metabolites.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341151     DOI: 10.1007/bf00250165

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

1.  Chlorpropamide alcohol flushing and diabetic retinopathy.

Authors:  R D Leslie; A H Barnett; D A Pyke
Journal:  Lancet       Date:  1979-05-12       Impact factor: 79.321

2.  Chlorpropamide-alcohol flushing and proteinuria in non-insulin-dependent diabetics.

Authors:  A H Barnett; R D Leslie; D A Pyke
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-14

3.  Blood intermediary metabolite and insulin concentrations after an overnight fast: reference ranges for adults, and interrelations.

Authors:  K J Foster; K G Alberti; L Hinks; B Lloyd; A Postle; P Smythe; D C Turnell; R Walton
Journal:  Clin Chem       Date:  1978-09       Impact factor: 8.327

4.  Endocrine effects of naloxone-induced opiate receptor blockade.

Authors:  J E Morley; N G Baranetsky; T D Wingert; H E Carlson; J M Hershman; S Melmed; S R Levin; K R Jamison; R Weitzman; R J Chang; A A Varner
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

5.  Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate.

Authors:  B Lloyd; J Burrin; P Smythe; K G Alberti
Journal:  Clin Chem       Date:  1978-10       Impact factor: 8.327

6.  Insulin secretion in the diagnosis of adult-onset diabetes mellitus.

Authors:  R W Turkington; H K Weindling
Journal:  JAMA       Date:  1978-09-01       Impact factor: 56.272

7.  Hormonal and metabolic responses to an enkephalin analogue in normal man.

Authors:  W A Stubbs; G Delitala; A Jones; W J Jeffcoate; C R Edwards; S J Ratter; G M Besser; S R Bloom; K G Alberti
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

8.  Sensitivity to enkephalin as a cause of non-insulin dependent diabetes.

Authors:  R D Leslie; D A Pyke; W A Stubbs
Journal:  Lancet       Date:  1979-02-17       Impact factor: 79.321

9.  Chlorpropamide-alcohol flushing and large-vessel disease in non-insulin-dependent diabetes.

Authors:  A H Barnett; D A Pyke
Journal:  Br Med J       Date:  1980-07-26

10.  Effect of enkephalins and morphine on insulin secretion from isolated rat islets.

Authors:  I C Green; D Perrin; K C Pedley; R D Leslie; D A Pyke
Journal:  Diabetologia       Date:  1980-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.